Exact Mass: 442.1652
Exact Mass Matches: 442.1652
Found 153 metabolites which its exact mass value is equals to given mass value 442.1652
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cortisol 21-sulfate
Cortisol 21-sulfate is also known as Cortisol-21-sulfuric acid or 4-Pregnen-11,17,21-triol-3,20-dione 21-sulfate. Cortisol 21-sulfate is considered to be practically insoluble (in water) and acidic. Cortisol 21-sulfate is a steroid conjugate lipid molecule D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Eltrombopag
B - Blood and blood forming organs > B02 - Antihemorrhagics > B02B - Vitamin k and other hemostatics COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78275 - Agent Affecting Blood or Body Fluid Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
beta-D-Xylopyranosyl-(1->4)-alpha-L-rhamnopyranosyl-(1->2)-D-fucose
beta-D-Xylopyranosyl-(1->4)-alpha-L-rhamnopyranosyl-(1->2)-D-fucose is a constituent of desacylsaponins from the bark of Quillaja saponaria (soapbark tree). Constituent of desacylsaponins from the bark of Quillaja saponaria (soap-bark tree)
3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine
3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine is an acylcarnitine. More specifically, it is an 3-[(2R)-2-hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
Eltrombopag
B - Blood and blood forming organs > B02 - Antihemorrhagics > B02B - Vitamin k and other hemostatics COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78275 - Agent Affecting Blood or Body Fluid Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
16,19-Secostrychnidine-10,16-dione, 21,22-epoxy-21,22-dihydro-4,14-dihydroxy-3-methoxy-19-methyl-, (21.alpha.,22.alpha.)-
(1S,3R,5S,6S,8S,9S,10R,13R)-1-acetoxy-3-bromo-6-hydroxy-8,13-epoxylabd-14-ene
Dienestrol glucuronide|O1-[alpha,alpha-Di-((E)-aethyliden)-4-hydroxy-bibenzyl-4-yl]-beta-D-glucopyranuronsaeure|O1-[alpha,alpha-di-((E)-ethylidene)-4-hydroxy-bibenzyl-4-yl]-beta-D-glucopyranuronic acid
8-(4-Hydroxyphenylactyl),Me ester-6,8,15-Trihydroxy-2-oxo-1(10),3,11(13)-guaiatrien-12-oic acid|Methyl 2-oxo-6alpha,15-dihydroxy-8alpha-(p-hydroxyphenylacetoxy)-guaia-1(10),3,11-trien-5alphaH-12-oate
2-(3,4-Dimethoxyphenyl)-3,5-dimethoxy-7-(2-hydroxy-3-methyl-3-butenyloxy)-4H-1-benzopyran-4-one
BENZYL 2,3-DI-O-ACETYL-4,6-O-BENZYLIDEN-|A-D-GLUCOPYRANOSIDE
3,4,17-trihydroxy-6,7-didehydro-aspidofractinine-1,3-dicarboxylic acid dimethyl ester|ent-(2S)-3alpha,4xi,17-Trihydroxy-6,7-didehydro-aspidofractinin-1,3beta-dicarbonsaeure-dimethylester|ent-(2S)-3alpha,4xi,17-trihydroxy-6,7-didehydro-aspidofractinine-1,3beta-dicarboxylic acid dimethyl ester|Kopsaporin
O-alpha-L-rhamnopyranosyl-(1-2)-O-alpha-L-rhamnopyranosyl-(1-5)-L-arabinose
C24H26O8_Spiro[furo[4,3,2-ij]pyrano[4,3:4,5]cyclohepta[1,2-f][2]benzopyran-7(9H),2-oxirane]-1,5,9,13(2H,3aH,11H)-tetrone, 5a,6,6a,13a,13b,13c-hexahydro-2,5a,11,11,13a-pentamethyl
Cys His Pro Ser
Cys His Ser Pro
Cys Pro His Ser
Cys Pro Ser His
Cys Ser His Pro
Cys Ser Pro His
Asp Asp Pro Pro
Asp Pro Asp Pro
Asp Pro Pro Asp
His Cys Pro Ser
His Cys Ser Pro
His Pro Cys Ser
His Pro Ser Cys
His Ser Cys Pro
His Ser Pro Cys
Pro Cys His Ser
Pro Cys Ser His
Pro Asp Asp Pro
Pro Asp Pro Asp
Pro His Cys Ser
Pro His Ser Cys
Pro Pro Asp Asp
Pro Ser Cys His
Pro Ser His Cys
Ser Cys His Pro
Ser Cys Pro His
Ser His Cys Pro
Ser His Pro Cys
Ser Pro Cys His
Ser Pro His Cys
Ser Ser Ser Tyr
Ser Ser Tyr Ser
Ser Tyr Ser Ser
Tyr Ser Ser Ser
b-D-Xylopyranosyl-(1->4)-a-L-rhamnopyranosyl-(1->2)-D-fucose
ST 21:3;O5;S
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
acetyl 4-[6-(4-acetyloxycarbonylphenoxy)hexoxy]benzoate
Benzo[1,2-b:4,5-b]dithiophene, 2,6-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)
Acepromazine maleate
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist
(-)-1,1-bis((2s,4s)-2,4-diethylphosphotano)ferrocene
(s)-1-[(1r)-2-(diphenylphosphino)ferrocenyl]ethyldi-tert-butylphosphine
BRL 15572 hydrochloride
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists
(1-Tert-Butyl-5-Hydroxy-1h-Pyrazol-4-Yl)[6-(Methylsulfonyl)-4-Methoxy-2-Methyl-1,1-Biphenyl-3-Yl]methanone
3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine
N-(3,4-dimethylphenyl)-2-[N-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-4-methoxyanilino]acetamide
[4-methoxy-3-(4-morpholinylsulfonyl)phenyl]-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)methanone
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
methyl (1R,9S,10R,11R,17S)-14-ethenyl-13-(2-hydroxyacetyl)oxy-12,21-dioxa-8,18-diazahexacyclo[9.9.1.01,9.02,7.09,17.010,15]henicosa-2,4,6-triene-10-carboxylate
11,17-Dihydroxy-3,20-dioxopregn-4-en-21-yl hydrogen sulfate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
cortisol 21-sulfate
A steroid sulfate obtained by the formal condensation of hydroxy group at position 21 of cortisol with sulfuric acid. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
2-({4,5-dihydroxy-6-methyl-2-[(3,4,5-trihydroxyoxolan-2-yl)methoxy]oxan-3-yl}oxy)-6-methyloxane-3,4,5-triol
4-{4-[4-(acetyloxy)-3-methoxyphenyl]-hexahydrofuro[3,4-c]furan-1-yl}-2-methoxyphenyl acetate
18,19-dimethoxy-13,14-dimethyl-20-oxo-3,6,8-trioxapentacyclo[9.9.1.0¹,¹⁶.0⁴,²¹.0⁵,⁹]henicosa-4,9,11(21),16,18-pentaen-12-yl acetate
23-hydroxy-17,18-dimethoxy-7,10-dioxa-4,14-diazaheptacyclo[10.8.3.2¹¹,¹⁴.0¹,¹³.0⁶,⁸.0⁶,²³.0¹⁵,²⁰]pentacosa-15(20),16,18-triene-21,24-dione
(2s,3r,4r,5r,6s)-2-{[(2r,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-2-{[(2s,3r,4r,5s)-3,4,5-trihydroxyoxolan-2-yl]methoxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol
2-[(5-heptyl-7-hydroxy-4-oxochromen-2-yl)methyl]-3,4,6-trihydroxybenzoic acid
acetoxyl oxokadsurane
{"Ingredient_id": "HBIN014435","Ingredient_name": "acetoxyl oxokadsurane","Alias": "NA","Ingredient_formula": "C24H26O8","Ingredient_Smile": "CC1CC2=CC(=C(C(=O)C23COC4=C3C(=CC5=C4OCO5)C(C1C)OC(=O)C)OC)OC","Ingredient_weight": "442.5 g/mol","OB_score": "28.59565179","CAS_id": "NA","SymMap_id": "SMIT11596","TCMID_id": "NA","TCMSP_id": "MOL010567","TCM_ID_id": "NA","PubChem_id": "49770118","DrugBank_id": "NA"}